Derbyshire medical test manufacturers SureScreen Diagnostics has been recognised as the pride of the East Midlands after it was put forward for a national business award for its rapid growth.
The company, based in Derby, has reached the finals of the British Chamber of Commerce Business Awards, which is a national search for companies who have best typified business excellence over the past two years.
SureScreen was successful at the East Midlands Chamber’s annual awards last year, picking up the Outstanding Growth, Excellence in International Trade and Excellence in Innovation awards, as well as the overall Derbyshire Business of the Year award.
It is now the East Midlands Chamber’s nominee for the national BCC awards’ Rapid Riser award, for companies who can demonstrate exceptional levels of growth and a strong plan for sustainable financial performance.
It is one of 11 companies from across the UK on the national shortlist for the Rapid Riser award, with the winner set to be announced in mid-October.
SureScreen won plaudits after developing the first European Lateral Flow Test to pass Public Health England laboratory validation during the pandemic, however, is known in the medical industry for a wide range of tests from fertility screening to workplace drugs of abuse testing.
Manufacturing out of a new, state-of-the-art production and distribution centre just off the M1, SureScreen exports to more than 60 countries worldwide, and continues to innovate, with recent development of rapid tests for Monkeypox.
Alastair Campbell, a director of the company, said: “We are so grateful to be recognised for such a prestigious award, it is really a testament to the team’s hard work over many years.
“Since the recognition last year we have certainly not stood still, and we are building new technologies and tests that we believe will have huge impacts on people’s health.
“Now that rapid testing is a much more accepted practice across the world, we believe there are huge opportunities for healthcare to increase the prevention of illnesses, by catching issues early using cost-effective, accurate rapid tests. This could help save lives and reduce the costs and pressures on healthcare.”
